AstraZeneca: UK-based pharmaceutical company with a strong oncology pipeline.
Price
162.85
24H
—
Volume 24h
$14.96K
Market Cap
—
| Venues | Issuers | Symbol | Mark | Volume 24h | Liquidity | Vol % | Contract |
|---|---|---|---|---|---|---|---|
 Gate |  | AZNX_USDT | 162.85 | $14.96K | — | 100.0% | Xs3ZFk…wAKU |
 Solana | | Xs3ZFk…z3wAKU | 162.91 | — | $1.32K | — | Xs3ZFk…wAKU |
News
15AZN▼AstraZeneca breast-cancer drug fails late-stage trial goal
9dAZN▲AstraZeneca tozorakimab cuts COPD exacerbations by 29% in TITANIA
×215dAZN▲AZN listed on BingX
15dAZN▲FDA grants accelerated approval to AstraZeneca's Etcamah for breast cancer
×218dAZN▼AstraZeneca terminates volrustomig lung cancer trial, efficacy falls short of Keytruda.
×22026-08-17